ACETYL CARNITINE AS A TREATMENT FOR ALZHEIMERS DISEASE

  • Mayeux, Richard (PI)
  • Sano, Mary (PI)

Project: Research project

Project Details

Description

Acetyl-Carnitine is a compound which has two primary actions: it is possibly a cholinergic agonist and it may enhance cerebral metabolism by activating mitochondrial activity. Its efficacy in Alzheimer's disease is suggested by animal studies and this is the first US clinical trial of this agent. A parallel double blind study of 25 subjects will take place as a preliminary study to determine whether a nation-wide trial should take place.
StatusFinished
Effective start/end date10/1/959/30/99

Funding

  • National Center for Research Resources

ASJC Scopus Subject Areas

  • Clinical Neurology
  • Neurology

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.